Abingdon Health is a developer and manufacturer of rapid lateral flow tests, providing contract development and manufacturing organization (CDMO) and contract research organization (CRO) services to various sectors including healthcare and environmental.

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

ABDX

COM:ABINGDONHEALTH

Abingdon Health

Last Close

7.25

21/11 11:59

Market Cap

143.03K

Beta: -

Volume Today

2.23K

Avg: -

locale

market

industry

website

ipo date

competitor of

Metrics